Skip to content
TrialScanner

NCT05869669

RewinD-LB - Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies

Phase 2CompletedCRVOCollaborator

Registry record

Lead sponsor
EIP Pharma Inc
Conditions
Dementia With Lewy Bodies
Primary completion
May 29, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05869669 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05869669: RewinD-LB - Clinical Study... | TrialScanner